In August 2018, the Michigan Opioid Prescribing and Engagement Network developed a pathway for managing pain that included counseling about pain management without opioids before surgery and prescriptions for nonopioid drugs for the week after surgery along with a predetermined prescription for oxycodone tablets, an opioid, for the first two days after surgery.
Simultaneously, Blue Cross Blue Shield of Michigan offered a financial incentive for using this pathway, a 35 percent reimbursement added to surgeons’ professional fees.
For the study, researchers examined 1,459 operations performed at Ann Arbor-based University of Michigan Health System from Aug. 1, 2018, to March 31.
Of the 1,459 operations, 70.4 percent included use of the opioid-sparing pathway. The median utilization rate of this pathway was 91.7 percent. Surgeons attested to using the pathway in 50 percent of the cases, and they received reimbursement ranging from $389 to $753 per operation.
The rate of surgeons providing evidence that they used the pathway increased from 38.1 percent to 60.7 percent during the study period.
More articles on opioids:
Ineffective drug rehab often costs families thousands
These 3 factors will define nurses’ roles in fighting the opioid epidemic
Penn Medicine center blends radiology, psychiatry for precision approach to opioid treatment
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
